<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>T1 Diabetes Research | t1diabetes-research.edu</title>
    <link rel="stylesheet" href="styles.css">
    <!-- Add Bootstrap CSS -->
    <link href="https://stackpath.bootstrapcdn.com/bootstrap/4.5.2/css/bootstrap.min.css" rel="stylesheet">
</head>
<body>
    <!-- <div class="disclaimer">
        <p>‚ö†Ô∏è Disclaimer: This is  part of a classroom assignment </p>
    </div> -->
    <header>
        <h1>All about Type 1 Diabetes</h1>
        <nav>
            <ul>
                <li><a href="index.html">Home</a></li>
                <li><a href="overview.html">Overview</a></li>
                <li><a href="symptoms.html">Symptoms</a></li>
                <li><a href="treatment.html">Treatment</a></li>
                <li><a href="research.html">Latest Research</a></li>
                <li><a href="resources.html">FAQs and References</a></li>
                <li><a href="about.html">About Me</a></li>
            </ul>
        </nav>
    </header>

    <main class="container my-5">
        <section>
            <h2>
                üî¨ Latest Research & Innovations in Type 1 Diabetes
            </h2>
            <p>Ongoing scientific advancements built new hope for improved treatments and potential cures for Type 1 Diabetes (T1D). Researchers are exploring ways to prevent autoimmune destruction, regenerate insulin-producing cells, and even modify genes to prevent or reverse the disease. Below are discussed a few advancing topics of research.</p>
        </section>
        <section>
            <h2 class="text-dark mb-4"> üß¨ Current Scientific Approaches</h2>
            <div class="card bg-light mb-4">
                <div class="card-body">
                    <ul class="list-group list-group-flush">
                        <li class="list-group-item">
                            <h5 class="mb-2"><span class="badge badge-primary">1</span> Immunotherapy & Beta Cell Regeneration</h5>
                            <p>One of the key challenges in Type 1 Diabetes is the autoimmune attack that destroys insulin-producing beta cells in the pancreas. Immunotherapy aims to halt or reduce this immune response.</p>
                            <h6>Breakthroughs in Immunotherapy:</h6>
                            <ul>
                                <li>Teplizumab (Tzield): The first FDA-approved drug that can delay the onset of Type 1 Diabetes in at-risk individuals by modifying immune responses.</li>
                                <li>T-Reg (Regulatory T Cell) Therapy: Enhancing the function of T-reg cells to prevent immune attack on beta cells.</li>
                                <li>Anti-CD3 & Other Monoclonal Antibodies: Targeting specific immune pathways to prevent beta cell destruction.</li>
                            </ul>
                            <h6>Beta Cell Regeneration:</h6>
                            <ul>
                                <li>Stimulating existing beta cells to multiply.</li>
                                <li>Reprogramming other pancreatic cells to function like beta cells.</li>
                            </ul>
                        </li>
                        <li class="list-group-item">
                            <h5 class="mb-2"><span class="badge badge-primary">2</span> Stem Cell Research & Islet Transplantation</h5>
                            <p>Stem cell therapy is one of the most promising approaches to restoring insulin production in people with Type 1 Diabetes.</p>
                            <h6>Stem Cell-Based Insulin Therapy:</h6>
                            <ul>
                                <li>Vertex Pharmaceuticals' VX-880 Therapy: A clinical trial using stem cell-derived islet cells to replace destroyed beta cells.</li>
                                <li>ViaCyte's PEC-Encap & PEC-Direct: Encapsulated stem cell-derived beta cells that can produce insulin while being protected from immune attack.</li>
                            </ul>
                            <h6>Islet Cell Transplantation:</h6>
                            <ul>
                                <li>Pancreatic islet cell transplants from donors can restore insulin production, but widespread use is limited due to the need for immunosuppressive drugs.</li>
                                <li>Encapsulation Technologies: Protective coatings around transplanted islets may eliminate the need for long-term immune suppression.</li>
                            </ul>
                        </li>
                        <li class="list-group-item">
                            <h5 class="mb-2"><span class="badge badge-primary">3</span> Gene Therapy & CRISPR Applications</h5>
                            <p><strong>Gene therapy is revolutionizing</strong> the way researchers think about curing Type 1 Diabetes by directly modifying genes to improve insulin production and immune regulation.</p>
                            <h6>Key Innovations in Gene Therapy:</h6>
                            <ul>
                                <li><strong>CRISPR-Cas9 Gene Editing:</strong> Scientists are exploring ways to edit genes in pancreatic cells to make them resistant to autoimmune attack.</li>
                                <li><strong>Genetically Modified Islet Cells:</strong> Engineering beta cells that can produce insulin without being destroyed by the immune system.</li>
                                <li><strong>Autoimmune Modulation:</strong> Gene therapy approaches that modify the immune system to tolerate insulin-producing cells instead of attacking them.</li>
                            </ul>
                            <h6>Exciting Possibility:</h6>
                            <p><strong>One approach being studied</strong> is modifying gut or liver cells to produce insulin, bypassing the immune destruction of pancreatic beta cells.</p>
                        </li>
                        <li class="list-group-item">
                            <h5 class="mb-2"><span class="badge badge-primary">4</span> Recent Clinical Trials & Findings</h5>
                            <p><strong>Several groundbreaking clinical trials</strong> are paving the way for new treatments and possible cures for Type 1 Diabetes.</p>
                            <h6>Notable Clinical Trials:</h6>
                            <ul>
                                <li><strong>Inhaled Insulin:</strong> Inhalational insulin is an effective alternative for systemic administration of insulin given its accessibility and large alveolar-capillary network of lungs for drug absorption, also reduces the pain of penetrative drug administration among type 1 diabetics. Afrezza, inhaled insulin has been recently approved by the Food and Drug Administration (FDA).</li>
                                <li><strong>Vertex Pharmaceuticals (VX-880 & VX-264):</strong> Testing stem cell-derived islet transplants that could restore natural insulin production.</li>
                                <li><strong>Teplizumab (Tzield) Trial:</strong> Confirmed that delaying Type 1 Diabetes onset by at least two years is possible with early intervention.</li>
                                <li><strong>IMCY-0098 (Autoimmune Vaccine):</strong> A peptide-based immunotherapy designed to train the immune system not to attack beta cells.</li>
                                <li><strong>Smart Insulin Trials:</strong> Research is underway on insulin that activates only when needed, reducing the risk of hypoglycemia.</li>
                            </ul>
                            <p><strong>Many of these trials</strong> are in advanced phases, showing promising results in improving diabetes management or potentially reversing the disease.</p>
                        </li>
                        <li class="list-group-item">
                            <h5 class="mb-2"><span class="badge badge-primary">5</span> Future Directions in Type 1 Diabetes Research</h5>
                            <p>The future of Type 1 Diabetes treatment is focused on curing the disease rather than just managing it. Scientists are actively exploring:</p>
                            <ul>
                                <li><strong>Artificial Pancreas Evolution:</strong> AI-driven insulin delivery systems that fully automate blood sugar control.</li>
                                <li><strong>Personalized Medicine for Type 1 Diabetes:</strong> Tailoring treatments based on genetic and autoimmune profiles.</li>
                                <li><strong>Oral Insulin & Smart Insulin Formulations:</strong> Developing pills or inhalable insulin to replace injections.</li>
                                <li><strong>Nanotechnology for Insulin Delivery:</strong> Microscopic nanoparticles that release insulin only when blood sugar is high.</li>
                                <li><strong>Bioengineered Beta Cells:</strong> Creating lab-grown beta cells that are resistant to autoimmune destruction.</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </section>
    </main>

    <footer>
        <p>¬© 2025 Type 1 Diabetes Research Project</p>
    </footer>

    <!-- Add Bootstrap JS and dependencies -->
    <script src="https://code.jquery.com/jquery-3.5.1.slim.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/@popperjs/core@2.9.3/dist/umd/popper.min.js"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.5.2/js/bootstrap.min.js"></script>
</body>
</html>